MediciNova Announces Positive Preliminary Results From a Multi-Day, Repeat … – NASDAQ

MediciNova Announces Positive Preliminary Results From a Multi-Day, Repeat …
NASDAQ
"There is a significant unmet medical need for an IV agent like MN-221 for asthma and COPD patients who are admitted to the ER due to a severe episode that is unresponsive to standard therapy," said Kazuko Matsuda, M.D., Ph.D., M.P.H, Chief Medical …

and more »